Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $308B |
| FY2017, ended Dec 31, 2017 | $367B |
| FY2018, ended Dec 31, 2018 | $320B |
| FY2019, ended Dec 31, 2019 | $429B |
| FY2020, ended Dec 31, 2020 | $388B |
| FY2021, ended Dec 31, 2021 | $468B |
| FY2022, ended Dec 31, 2022 | $395B |
| FY2023, ended Dec 31, 2023 | $490B |
| FY2024, ended Dec 31, 2024 | $670B |
| FY2025, ended Dec 31, 2025 | $869B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $870B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $96.6B |
| FY2017, ended Dec 31, 2017 | $101B |
| FY2018, ended Dec 31, 2018 | $109B |
| FY2019, ended Dec 31, 2019 | $116B |
| FY2020, ended Dec 31, 2020 | $120B |
| FY2021, ended Dec 31, 2021 | $122B |
| FY2022, ended Dec 31, 2022 | $129B |
| FY2023, ended Dec 31, 2023 | $158B |
| FY2024, ended Dec 31, 2024 | $178B |
| FY2025, ended Dec 31, 2025 | $182B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $199B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $24.7B |
| FY2017, ended Dec 31, 2017 | $24.4B |
| FY2018, ended Dec 31, 2018 | $32.5B |
| FY2019, ended Dec 31, 2019 | $36.4B |
| FY2020, ended Dec 31, 2020 | $29.1B |
| FY2021, ended Dec 31, 2021 | $48.3B |
| FY2022, ended Dec 31, 2022 | $37.7B |
| FY2023, ended Dec 31, 2023 | $49.6B |
| FY2024, ended Dec 31, 2024 | $58.5B |
| FY2025, ended Dec 31, 2025 | $57.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $65.1B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $391B |
| FY2017, ended Dec 31, 2017 | $431B |
| FY2018, ended Dec 31, 2018 | $279B |
| FY2019, ended Dec 31, 2019 | $264B |
| FY2020, ended Dec 31, 2020 | $528B |
| FY2021, ended Dec 31, 2021 | $741B |
| FY2022, ended Dec 31, 2022 | $567B |
| FY2023, ended Dec 31, 2023 | $624B |
| FY2024, ended Dec 31, 2024 | $469B |
| FY2025, ended Dec 31, 2025 | $343B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $310B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $330B |
| FY2017, ended Dec 31, 2017 | $336B |
| FY2018, ended Dec 31, 2018 | $351B |
| FY2019, ended Dec 31, 2019 | $332B |
| FY2020, ended Dec 31, 2020 | $327B |
| FY2021, ended Dec 31, 2021 | $355B |
| FY2022, ended Dec 31, 2022 | $340B |
| FY2023, ended Dec 31, 2023 | $437B |
| FY2024, ended Dec 31, 2024 | $454B |
| FY2025, ended Dec 31, 2025 | $500B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $533B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 25.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 3.57B |
| FY2017, ended Dec 31, 2017 | 3.43B |
| FY2018, ended Dec 31, 2018 | 3.27B |
| FY2019, ended Dec 31, 2019 | 3.07B |
| FY2020, ended Dec 31, 2020 | 3.05B |
| FY2021, ended Dec 31, 2021 | 2.95B |
| FY2022, ended Dec 31, 2022 | 2.94B |
| FY2023, ended Dec 31, 2023 | 2.88B |
| FY2024, ended Dec 31, 2024 | 2.80B |
| FY2025, ended Dec 31, 2025 | 2.70B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 2.66B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $9.08B | $1.94B |
| FY2017, ended Dec 31, 2017 | $15.4B | $2.07B |
| FY2018, ended Dec 31, 2018 | $20.0B | $2.32B |
| FY2019, ended Dec 31, 2019 | $24.0B | $2.26B |
| FY2020, ended Dec 31, 2020 | $6.52B | $2.45B |
| FY2021, ended Dec 31, 2021 | $18.4B | $2.93B |
| FY2022, ended Dec 31, 2022 | $3.16B | $2.79B |
| FY2023, ended Dec 31, 2023 | $9.82B | $3.12B |
| FY2024, ended Dec 31, 2024 | $18.8B | $3.50B |
| FY2025, ended Dec 31, 2025 | $31.6B | $3.61B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $31.7B | $3.94B |
Valuation
At current price- Market Cap
- $893B
- P/E
- 13.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.5×
- Price / Book
- 2.4×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $199B
- Revenue Growth YoY
- 13.5%
- Revenue CAGR 3Y
- 12.3%
- Revenue CAGR 5Y
- 8.7%
- EPS Growth YoY
- 19.7%
- Net Income Growth YoY
- 15.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 32.6%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 17.8%
Earnings
Trailing 12 months- Net Income
- $65.1B
- EPS (diluted)
- $23.34
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $310B
- Total Debt
- $533B
- Net Debt
- $223B
- Total Assets
- $5.02T
- Total Liabilities
- $4.64T
- Shareholders' Equity
- $375B
Cash Flow
Trailing 12 months- Operating Cash Flow
- −$163B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 1.8%
- Dividend / Share
- $6.15
- Beta (5Y)
- 1.02
Every ratio is calculated from the company’s reported figures.